PAPER
Succinylation of Tertiary Alcohols Under High Pressure
1033
1H NMR (500 MHz, CDCl3): = 1.41 (s, 3 H), 1.44 (s, 3 H), 1.64
(br s, 3 H), 1.75–2.08 (m, 7 H), 2.52–2.64 (m, 4 H), 5.36 (br s, 1 H).
13C NMR (125 MHz, CDCl3): = 23.1, 23.3, 23.3, 23.8, 26.3, 29.1,
30.1, 37.3, 42.6, 85.8, 120.2, 133.9, 171.3, 178.2.
IR (neat): = 2965, 2935, 1732, 1717, 1370 cm–1.
(2) (a) Michael, K. H.; Demarco, P. V.; Nagarajan, R. J. J.
Antibiot. 1977, 30, 571. (b) Arai, K.; Rawlinga, B. J.;
Yoshizawa, Y.; Vederas, J. C. J. Am. Chem. Soc. 1989, 111,
3391.
(3) Koshino, H.; Kobinata, K.; Uzawa, J.; Uramoto, M.; Isono,
K.; Osada, H. Tetrahedron 1993, 49, 8827.
(4) (a) Yamamoto, R.; Fujisawa, S.; Kawamura, M. Yakugaku
Zasshi 1971, 91, 855. (b) Chem. Abstr. 1971, 75, 118453.
(5) Israel, M.; Potti, P. G.; Seshadri, R. J. Med. Chem. 1985, 28,
1223.
(6) Tsuchiya, T.; Takagi, Y.; Umezawa, S.; Takeuchi, T.;
Komuro, K.; Nosaka, C.; Umezawa, H.; Fukatsu, S.; Yoneta,
T. J. Antibiot. 1988, 41, 988.
(7) Magri, N. F.; Kingston, D. G. I. J. Nat. Prod. 1988, 51, 298.
(8) Deutsch, H. M.; Glinski, J. A.; Hernandez, M.; Haugwitz, R.
D.; Narayanan, V. L.; Suffness, M.; Zalkow, L. H. J. Med.
Chem. 1989, 32, 788.
(9) Nicolaou, K. C.; Riemer, C.; Kerr, M. A.; Rideout, D.;
Wrasidlo, W. Nature 1993, 364, 464.
(10) (a) Kita, Y.; Maeda, H.; Omori, K.; Okuno, T.; Tamura, Y.
Synlett 1993, 273. (b) Kita, Y.; Maeda, H.; Takahashi, F.;
Fukui, S. J. Chem. Soc., Chem. Commun. 1993, 410.
(11) Saitoh, K.; Siina, I.; Mukaiyama, T. Chem. Lett. 1998, 679.
(12) Shimizu, T.; Kobayashi, R.; Ohmori, H.; Nakata, T. Synlett
1995, 650.
HRMS (FAB, M + Na+): m/z calcd for C14H22O4Na 277.1416, found
277.1415.
Succinic Acid (2S,3R,6S,8R,9S)-Mono-{3-butyl-2-[(1E,3E)-4-
carboxy-3-methylbuta-1,3-dienyl]-8-(2-hydroxyethyl)-9-
methyl-1,7-dioxaspiro[5.5]undec-3-yl} Ester (35)
Following the typical procedure for the preparation of 32, the
hemisuccinate 35 was formed from 34 (5.8 mg, 0.01 mmol) as a col-
orless oil in 88% yield; Rf 0.45 (CH2Cl2–MeOH, 85:15).
1H NMR (500 MHz, CD3OD): = 0.89 (d, J = 6.0 Hz, 3 H), 0.90 (t,
J = 6.9 Hz, 3 H), 1.10–2.20 (m, 17 H), 2.33 (d, J = 0.9 Hz, 3 H),
2.50–2.80 (m, 4 H), 3.51 (m, 1 H), 3.70–3.80 (m, 2 H), 4.68 (d,
J = 7.8, 1 H), 5.91 (br s, 1 H), 6.43 (dd, J = 15.6, 7.8 Hz, 1 H), 6.47
(d, J = 15.6, 1 H).
IR (neat): = 3500, 2958, 2935, 2855, 1733, 1717, 1610, 1514 cm–1.
HRMS (FAB, M + Na+): m/z calcd for C26H40O9Na 519.2570, found
519.2567.
Succinic Acid (2S,3R,6S,8R,9S)-Mono-{3-butyl-2-[(1E,3E)-4-
carboxy-3-methylbuta-1,3-dienyl]-8-(4-hydroxy-3-methylbut-
2-enyl)-9-methyl-1,7-dioxaspiro[5.5]undec-3-yl} Ester (37)
(13) Shimizu, T.; Kobayashi, R.; Osako, K.; Nakata, T.
Tetrahedron Lett. 1996, 37, 6755.
(14) Shimizu, T.; Masuda, T.; Hiramoto, K.; Nakata, T. Org. Lett.
2000, 2, 2153.
Following the typical procedure for the preparation of 32, the
hemisuccinate 37 was formed from 36 (6.2 mg, 0.01 mmol) as a col-
orless oil in 87% yield; Rf 0.45 (CH2Cl2–MeOH, 85:15).
1H NMR (500 MHz, CD3OD): = 0.83 (d, J = 6.0 Hz, 3 H), 0.89 (t,
J = 6.9 Hz, 3 H), 1.20–1.90 (m, 16 H), 1.71 (s, 3 H), 2.05 (m, 1 H),
2.31 (d, J = 1.4 Hz, 3 H), 2.58–2.70 (m, 4 H), 3.48 (dt, J = 9.6, 4.1
Hz, 1 H), 3.97 (s, 2 H), 4.66 (d, J = 8.7, 1 H), 5.57 (br t, J = 6.4 1 H),
5.92 (br s, 1 H), 6.46 (d, J = 15.6 Hz, 1 H), 6.51 (dd, J = 15.6, 8.7 1
H).
13C NMR (125 MHz, CD3OD): = 14.1, 14.2, 14.5, 18.1, 23.8, 25.1,
25.5, 28.8, 29.9, 31.1, 32.2, 32.8, 34.4, 35.2, 36.8, 69.0, 76.2, 79.7,
84.2, 97.1, 121.6, 121.9, 134.3, 137.3, 139.1, 152.6, 170.2, 173.4,
175.9.
(15) The alcohol 7 was prepared from the known lactone 613 in
two steps:(1)LAH, THF, 0°C (90%);(2)BOMCl, i-Pr2NEt,
CH2Cl2, 0°C to r.t. (79%). 1H NMR (270 MHz, CDCl3):
= 0.92 (t, J = 6.7 Hz, 3 H), 1.20–1.80 (m, 10 H), 1.37 (s, 3
H), 1.42 (s, 3 H), 2.03 (s, 1 H), 3.54 (dt, J = 9.6, 6.3 Hz, 1 H),
3.60 (dt, J = 9.6, 6.3 Hz, 1 H), 3.87 (dd, J = 8.2, 7.8 Hz, 1 H),
3.93 (dd, J = 7.8, 6.1 Hz, 1 H), 4.03 (dd, J = 8.2, 6.1 Hz, 1 H),
4.60 (s, 2 H), 4.75 (s, 2 H), 7.25–7.40 (m, 5 H). 13C NMR
(67.5 MHz, CDCl3): = 14.2, 23.3, 23.5, 25.6, 25.8, 26.5,
31.0, 36.6, 64.6, 68.3, 69.3, 72.7, 79.8, 94.5, 108.7, 127.6,
127.7, 128.3, 128.4, 137.8.
(16) The alcohol 10 was prepared from the known amide 913 in
four steps:(1)DIBAH, Et2O, 0°C (90%);(2)CBr4, Ph3P, 2,6-
lutidine, CH2Cl2, 0°C (80%);(3)BuLi, THF, –78°C to r.t.
(68%);(4)MeI, NaHCO3, acetone, H2O, 60°C (83%). 1H
NMR (270 MHz, CDCl3): = 0.92 (t, J = 6.7, 3 H), 1.22–
1.36 (m, 4 H), 1.36 (s, 3 H), 1.42 (s, 3 H), 1.48–1.70 (m, 4
H), 1.97 (dd, J = 2.8, 2.8, 1 H), 2.22 (dddd, J = 16.6, 9.5, 7.2,
2.8, 1 H), 2.34 (dddd, J = 16.6, 9.2, 6.4, 2.8, 1 H), 3.87 (dd,
J = 7.9, 7.9, 1 H), 3.97 (dd, J = 7.9, 6.4, 1 H), 4.06 (dd,
J = 7.9, 6.4, 1 H). 13C NMR (67.5 MHz, CDCl3): = 12.7,
14.2, 23.3, 25.5, 25.9, 26.4, 33.1, 36.2, 62.5, 64.6, 72.9, 79.4,
84.3, 108.9.
(17) The alcohol 28 was prepared from the enantiomer of the
amide 912 using the same procedure for the preparation of
2413: 1H NMR (500 MHz, CDCl3): = 0.77 (d, J = 6.4 Hz, 3
H), 0.92 (t, J = 6.9 Hz, 3 H), 1.05 (s, 9 H), 1.20–1.80 (m, 16
H), 2.00 (m, 1 H), 3.36 (ddd, J = 10.1, 101, 2.3 Hz, 1 H), 3.62
(ddd, J = 9.2, 8.7, 6.9 Hz, 1 H), 3.69 (dd, J = 9.6, 6.9 Hz, 1
H), 3.73 (ddd, J = 9.2, 9.2, 5.0 Hz, 1 H), 3.77 (s, 3 H), 3.77
(dd, J = 6.9, 6.0 Hz, 1 H), 3.85 (dd, J = 9.6, 6.9 Hz, 1 H), 4.47
(d, J = 11.5 Hz, 1 H), 4.52 (d, J = 11.5 Hz, 1 H), 6.86 (d,
J = 8.7 Hz, 2 H), 7.28 (d, J = 8.7 Hz, 2 H), 7.30–7.80 (m, 10
H). 13C NMR (125 MHz, CDCl3): = 14.2, 17.6, 19.1, 23.4,
24.7, 26.8, 28.0, 29.5, 30.6, 33.4, 33.7, 35.0, 35.1, 55.2, 63.6,
67.3, 71.2, 72.2, 72.8, 74.4, 95.0, 113.8, 127.8, 127.8, 129.3,
129.8, 129.9, 130.8, 132.7, 132.8, 135.6, 135.7, 159.1.
IR (neat): = 3500, 2957, 2935, 2853, 1733, 1715, 1610, 1510 cm–1.
HRMS (FAB, M + Na+): m/z calcd for C29H44O9Na 559.2883, found
559.2875.
Acknowledgement
This work was supported in part by a Grant-in-Aid for Scientific
Research from the Ministry of Education, Science, Sports, and Cul-
ture, Japan, and by the Special Project Funding for Basic Science
(Multibioprobes) from RIKEN. We thank Messrs. A. Matsumoto
and T. Watanabe for operation of the high-pressure equipment, and
Ms. K. Harata for the mass spectral measurements.
References
(1) (a) Takahashi, H.; Osada, H.; Koshino, H.; Kudo, T.;
Amano, S.; Shimizu, S.; Yoshihama, M.; Isono, K. J.
Antibiot. 1992, 45, 1409. (b) Takahashi, H.; Osada, H.;
Koshino, H.; Sasaki, M.; Onose, R.; Nakakoshi, M.;
Yoshihama, M.; Isono, K. J. Antibiot. 1992, 45, 1414.
(c) Koshino, H.; Takahashi, H.; Osada, H.; Isono, K. J.
Antibiot. 1992, 45, 1420.
Synthesis 2001, No. 7, 1027–1034 ISSN 0039-7881 © Thieme Stuttgart · New York